Category: Vaccine Headlines
Battling Infectious Diseases in the 20th Century: The Impact of Vaccines
WSJ The number of infected people, measured over 70-some years and across all 50 states and the District of Columbia, generally declined after vaccines were introduced. The heat maps below show number of cases per 100,000 people.
Nov 12, 2024
Do the Covid vaccines provide long-lasting protection?
NBC News The CDC is recommending that older adults get a second Covid shot in the spring. How durable are the vaccines? In October, the Centers for Disease Control and Prevention recommended that high-risk adults get a second updated Covid vaccine to bolster their protection against the virus. The agency now recommends that people ages 65 and up and […]
Nov 6, 2024
Why protective antibodies fade after COVID-19 vaccines
NIH Some vaccines offer long-lasting protection. For instance, the tetanus vaccine provides protection for at least 10 years. With other vaccines, protection may begin to decline within a few months. To provide enduring immunity, a vaccine must elicit production of long-lived plasma cells, a type of immune cell that matures over time in the bone […]
Oct 30, 2024
Comparing the COVID-19 Vaccines: How Are They Different?
Yale Medicine COVID-19 is now in its fifth year, and the subvariants of the Omicron strain continue to drive infections in the United States. The good news is that vaccines, which have been updated each year since 2022, are still expected to be effective at preventing severe disease, hospitalization, and death from COVID. In the U.S., infants, children, […]
Oct 29, 2024
Why You Might Need Two COVID-19 Shots This Season
Time eniors and people who are immunocompromised should get not just one but two COVID-19 shots this respiratory virus season. That’s the new recommendation from the U.S. Centers for Disease Control and Prevention (CDC). People in these groups should get the vaccines six months apart in order to stay protected against the disease, the agency’s vaccine group […]
Oct 29, 2024
Pfizer’s RSVpreF Vaccine Shows Efficacy in High-Risk Adults Aged 18-59
Contagion C3671023 Substudy A (NCT05842967)(MONeT Study) is a phase 3, randomized, double-blind, placebo-controlled trial assessing the safety and immunogenicity of Pfizer’s RSVpreF vaccine in high-risk adults aged 18-59 with chronic medical conditions, such as pulmonary, cardiovascular, hepatic, renal, and metabolic disorders, including diabetes mellitus. The study aims to show that the immune response in this […]
Oct 23, 2024
Advanced technologies for the development of infectious disease vaccines
Nature Vaccines play a critical role in the prevention of life-threatening infectious disease. However, the development of effective vaccines against many immune-evading pathogens such as HIV has proven challenging, and existing vaccines against some diseases such as tuberculosis and malaria have limited efficacy. The historically slow rate of vaccine development and limited pan-variant immune responses […]
Oct 22, 2024
Mpox Vaccine in Teens Generates Robust Immune Response, Proves Safe
MedPageToday The modified vaccinia Ankara-Bavarian Nordic mpox vaccine (MVA-BN; Jynneos) generated robust immune responses in adolescents against mpox and was safe, according to an interim analysis of a phase II clinical trial. Two doses of the vaccine generated geometric mean titers (GMT) in adolescents (470.3, 95% CI 422.3-523.8) that were higher than titers in adults […]
Oct 22, 2024
Covid Shots Are Still Inconvenient Almost Four Years Later
Bloomberg Last month, I went to a nearby CVS, rolled up my sleeve, and got another Covid shot. Then, I went online to see how many other people did, too. The news was grim: So far, less than 5% of US adults have gotten the latest Covid vaccine. Analysts at Jefferies expect this year’s Covid immunization rate […]
Oct 8, 2024
CDC urges covid, flu shots, but public interest is flagging
Washington Post Federal health officials are urging Americans to get vaccinated ahead of the respiratory virus season as new survey data shows tepid interest in getting shots. Mandy Cohen, director of the Centers for Disease Control and Prevention, said the agency anticipates 800,000 flu, covid and respiratory syncytial virus (RSV) hospitalizations in the coming months, on par with […]
Oct 1, 2024